Literature DB >> 2157047

Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins.

P Dorn1, L DaSilva, L Martarano, D Derse.   

Abstract

Equine infectious anemia virus (EIAV) contains a tat gene which is closely related to the trans-activator genes of the human and simian immunodeficiency viruses. Nucleotide sequence analysis of EIAV cDNA clones revealed that the tat mRNA is composed of three exons; the first two encode Tat and the third may encode a Rev protein. Interestingly, EIAV Tat translation is initiated at a non-AUG codon in exon 1 of the mRNA, perhaps allowing an additional level of gene regulation. The deduced amino acid sequence of EIAV tat, combined with functional analyses of tat cDNAs in transfected cells, has provided some unique insights into the domain structure of Tat. EIAV Tat has a C-terminal basic domain and a highly conserved 16-amino-acid core domain, but not the cysteine-rich region, that are present in the primate immunodeficiency virus Tat proteins. Thus, EIAV encodes a relatively simple version of this kind of trans activator.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157047      PMCID: PMC249297          DOI: 10.1128/JVI.64.4.1616-1624.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.

Authors:  R A Olmsted; V M Hirsch; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat.

Authors:  L Sherman; A Gazit; A Yaniv; T Kawakami; J E Dahlberg; S R Tronick
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

3.  cis- and trans-acting regulation of gene expression of equine infectious anemia virus.

Authors:  P L Dorn; D Derse
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

4.  Sequence comparisons of retroviral proteins: relative rates of change and general phylogeny.

Authors:  M A McClure; M S Johnson; D F Feng; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas.

Authors:  S R Hann; M W King; D L Bentley; C W Anderson; R N Eisenman
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

6.  HIV-1 tat trans-activation requires the loop sequence within tar.

Authors:  S Feng; E C Holland
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

7.  Immunofluorescent localization of equine infectious anemia virus in tissue.

Authors:  T C McGuire; T B Crawford; J B Henson
Journal:  Am J Pathol       Date:  1971-02       Impact factor: 4.307

8.  A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator.

Authors:  A Jakobovits; D H Smith; E B Jakobovits; D J Capon
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

9.  Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group.

Authors:  M Fukasawa; T Miura; A Hasegawa; S Morikawa; H Tsujimoto; K Miki; T Kitamura; M Hayami
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

10.  Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA.

Authors:  J Curran; D Kolakofsky
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  45 in total

1.  Molecular dynamics simulations on HIV-1 Tat.

Authors:  Sergio Pantano; Mudit Tyagi; Mauro Giacca; Paolo Carloni
Journal:  Eur Biophys J       Date:  2003-11-08       Impact factor: 1.733

Review 2.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

3.  Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation.

Authors:  B Elangovan; T Subramanian; G Chinnadurai
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

4.  Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.

Authors:  S Alexandersen; S Carpenter
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Mutational analysis of the equine infectious anemia virus Tat-responsive element.

Authors:  M Carvalho; D Derse
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

6.  Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras.

Authors:  R Carroll; L Martarano; D Derse
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

7.  Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.

Authors:  D L Lichtenstein; K E Rushlow; R F Cook; M L Raabe; C J Swardson; G J Kociba; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element.

Authors:  A Sica; T H Tan; N Rice; M Kretzschmar; P Ghosh; H A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter.

Authors:  E Flory; A Hoffmeyer; U Smola; U R Rapp; J T Bruder
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Complete nucleotide sequence and transcriptional analysis of snakehead fish retrovirus.

Authors:  D Hart; G N Frerichs; A Rambaut; D E Onions
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.